Azitra, Inc. (AZTR) Financial Statements (2026 and earlier)

Company Profile

Business Address 21 BUSINESS PARK DRIVE, SUITE 6
BRANFORD, CT 06405
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,0684,5551,796
Cash and cash equivalent2,0684,5551,796
Receivables1  
Prepaid expense810568448
Deferred costs  468
Other undisclosed current assets140102223
Total current assets:3,0195,2282,536
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization92540
Operating lease, right-of-use asset404527829
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization549654710
Intangible asset, including goodwill, after accumulated amortization317246211
Intangible asset, excluding goodwill, after accumulated amortization317246211
Deferred costs680594742
Other noncurrent assets4747 
Other undisclosed noncurrent assets  3748
Total noncurrent assets:2,0062,1312,580
TOTAL ASSETS:5,0257,3595,115
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5971,0931,281
Accounts payable399490897
Accrued liabilities197603384
Debt101615
Other undisclosed current liabilities461267308
Total current liabilities:1,0681,3761,603
Noncurrent Liabilities
Long-term debt and lease obligation  1026
Finance lease, liability  1026
Liabilities, other than long-term debt156275573
Operating lease, liability156274538
Derivative instruments and hedges, liabilities  035
Total noncurrent liabilities:156285599
Total liabilities:1,2241,6612,202
Equity
Equity, attributable to parent3,8015,6982,913
Common stock111
Additional paid in capital72,32163,26351,510
Accumulated deficit(68,521)(57,566)(48,598)
Total equity:3,8015,6982,913
TOTAL LIABILITIES AND EQUITY:5,0257,3595,115

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
Revenues  8686
Gross profit:  8686
Operating expenses(10,967)(10,993)(8,302)
Operating loss:(10,967)(10,985)(7,616)
Nonoperating income (expense)202,027(3,650)
Other nonoperating income (expense)(43)1590
Interest and debt expense(8)(12)(166)
Loss from continuing operations before equity method investments, income taxes:(10,955)(8,971)(11,432)
Other undisclosed income from continuing operations before income taxes812166
Loss from continuing operations before income taxes:(10,947)(8,958)(11,266)
Income tax expense (8)(9)(17)
Other undisclosed loss from continuing operations   
Net loss attributable to parent:(10,955)(8,967)(11,284)
Preferred stock dividends and other adjustments   (1,355)
Net loss available to common stockholders, diluted:(10,955)(8,967)(12,639)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
Net loss:(10,955)(8,967)(11,284)
Comprehensive loss, net of tax, attributable to parent:(10,955)(8,967)(11,284)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: